The significance of PP2A methylation is further highlighted through the discovery that reduced PP2A methylation, reduced LCMT-1, and elevated PME-1 expression have been found in postmortem brains of PD and AD patients (Park et al., 2016, 2017). The gene discussed is LCMT1; the disease is Parkinson disease.